) handling is essential for the maintenance of normal excitation-contraction coupling [1] [2] [3] . Cardiac Na + channels open transiently and inactivate rapidly, causing a large, brief peak of Na + current that initiates the cardiac action potential [4, 5] . Under pathological conditions, including heart failure and myocardial ischemia, Na + channel inactivation is slowed and/or incomplete, resulting in a sustained Na + current, referred to as persistent or late Na + current (I NaL ) [3] [4] [5] . Increased I NaL promotes intracellular Na + overload, thereby reducing the electrochemical gradient for Ca 2+ extrusion by the Na + -Ca 2+ exchanger (NCX), causing cellular Ca 2+ overload, contractile dysfunction, and arrhythmias [3] [4] [5] .
In addition to increasing cytosolic Ca 2+ , intracellular Na + overload also perturbs mitochondrial Ca 2+ homeostasis, resulting in mitochondrial reactive oxygen species (ROS) generation [6] [7] [8] . Ca 2+ is an important regulator of the mitochondrial redox state [6] [7] [8] [9] [10] . Ca 2+ activates key rate-limiting enzymes of the Krebs cycle (pyruvate, isocitrate, and malate dehydrogenases) required for producing NADH (the main electron donor for ATP in the respiratory chain) and for regenerating NADPH (to maintain the antioxidative capacity of mitochondrial matrix enzymes) [9] . When cardiac work increases, mitochondrial Ca 2+ uptake is elevated to increase the Krebs cycle activity and ATP production to meet an increased metabolic demand [9] . An elevation of the cytosolic [Na + ], on the other hand, decreases mitochondrial Ca 2+ uptake and NADH levels [6] . In myocytes isolated from failing hearts, cytosolic Na + elevation promotes mitochondrial Ca 2+ efflux via the mitochondrial Na + -Ca 2+ exchanger, and thereby reduces the Krebs cycle activity and levels of NADH and NADPH [6, 7] . A decrease in the level of NADPH impairs the capacity of antioxidant enzymes such as thioredoxin and glutathione to reverse protein oxidation, thus increasing ROS-induced cellular dysfunction. Indeed, the elevated ROS in cardiomyocytes isolated from the failing heart can be normalized either by lowering cytosolic [Na + ] or by inhibiting mitochondrial Na + generation may play a critical contributory role in mediating the pathological effects of cytosolic Na + overload [2, 7, 8, 10] .
Elevated ROS production promotes adverse cardiac remodeling by activating intracellular signaling pathways that induce cardiomyocyte cell death, hypertrophy, and arrhythmia [11] . We previously demonstrated that the multi-functional Ca 2+ /calmodulin-dependent protein kinase II delta (CaMKIIδ) is activated in response to enhanced I NaL and mediates downstream pathological processes that include necrotic and apoptotic cardiac cell death and ventricular arrhythmia [12] . CaMKIIδ phosphorylates a number of substrates involved in cellular Ca 2+ homeostasis, including phospholamban (PLN), the sarcoplasmic reticulum (SR) Ca 2+ ATPase, ryanodine receptor 2 (RyR2), and the cardiac Na + channel, Na v 1.5. Phosphorylation of these proteins disrupts normal SR Ca 2+ cycling, promotes cellular Ca 2+ overload, induces spontaneous Ca 2+ release, and alters excitation-contraction coupling and propagation of electrical impulses [13] [14] [15] [16] [17] [18] . CaMKIIδ activity is regulated by Ca 2+ /calmodulin and depends on the amplitude and frequency of cytosolic Ca 2+ waves. CaMKIIδ activity is also regulated by direct oxidation of methionine 281/282 at its regulatory domain [11, 15] . Based on its dual modes of activation, CaMKIIδ is centrally poised to sense elevations in either Ca 2+ or ROS, and to initiate downstream molecular events that promote Ca 2+ mishandling. CaMKIIδ may therefore serve as a nodal point of convergence for pathological signaling events induced by an increased I NaL [12, 18] . Despite the well-established link between cytosolic Na + overload and altered intracellular Ca 2+ handling [3] [4] [5] [6] [7] [8] 12, [19] [20] [21] , the mechanism of Na + -dependent modulation of Ca 2+ dynamics is not fully understood [2] . In this study we tested the hypothesis that intracellular Na + overload caused by an enhanced I NaL increases mitochondrial ROS production, resulting in oxidation-induced activation of CaMKIIδ that in turn promotes Ca 2+ mishandling. Our experimental approaches to study the pathway between intracellular Na + overload and Ca 2+ mishandling included intact and permeabilized adult rabbit cardiomyocytes exposed to an enhancer of I NaL and an increased superfusate Na + concentration, respectively, and a mouse model of pressure overload-induced heart failure. Fluorescent dyes sensitive to Na + , Ca
2+
, and ROS were used to measure the effects of increased I NaL and intracellular Na + to alter ROS formation and cellular Ca 2+ handling. Anemonia sulcata toxin II (ATX-II) and ranolazine were used to increase and inhibit I NaL , respectively [22, 4] .
Materials and methods

Chemicals
ATX-II and tetrodotoxin were purchased from Alomone Labs and Tocris Bioscience, respectively. Dithiothreitol (DTT) and coenzyme Q10 (CoQ10) were purchased from Sigma Chemical. The CaMKII inhibitor KN-93 and its inactive analog KN-92 were purchased from EMD Millipore. Ranolazine and the selective I NaL blocker GS-967 [23] were provided by Gilead Sciences. The sources of fluorescent dyes and antibodies are indicated in the relevant sections below.
Cell isolation
Experimental protocols using animals were approved by the Gilead Institutional Animal Care and Use Committee following the criteria outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996). Adult female 2-3 kg New Zealand White rabbits (Western Oregon Rabbit Company) were sedated with intramuscular injections of 35 mg/kg ketamine and 5 mg/kg xylazine. The respiratory rate, muscle tone, and righting reflex were monitored to ensure sedation. Once sedated, rabbits were given 1 mL of heparin (1000 USP units/mL) into the ear vein and then deeply anesthetized by intravenous injection of 15 mg/mL ketamine and 3 mg/mL xylazine. Hearts were removed and mounted on a Langendorff apparatus for retrograde perfusion (17-20 mL/min) of the aorta with a perfusion solution containing (in mmol/L): 140 NaCl, 4.4 KCl, 1.5 MgCl 2 , 1 NaH 2 PO 4 , 5 HEPES, 7.5 glucose, 16 taurine, 5 Na pyruvate, and NaOH to adjust the pH to 7.3. Cardiac myocytes were enzymatically isolated from left ventricles as previously described by Brunner et al. [24] . The perfusion solution was supplemented with collagenase type II enzyme (0.8 mg/mL, Worthington), 0.2% 2,3-butanedione monoxime, and 0.2% bovine serum albumin. Left ventricles were dissected, chopped, and subjected to postdigestion in a shaker with periodical changes of an isolation solution. The isolation solution contained (in mmol/L): 140 NaCl, 4.6 KCl, 1.1 MgCl 2 , 1 NaH 2 PO 4 , 10 HEPES, 10 glucose, and NaOH to adjust the pH to 7.4. The isolation solution was supplemented with a low concentration (0.344 mg/mL) of collagenase and 0.975% albumin. All procedures were performed at 37°C. Isolated cardiomyocytes were used within 6 h after isolation.
Adult male mice were heparinized and sacrificed by cervical dislocation. The hearts were perfused on the Langendorff apparatus with the following solution (in mmol/L): 135 NaCl, 4.6 KCl, 1.1 MgCl 2 , 1 NaH 2 PO 4 , 10 HEPES, 10 glucose, and NaOH to adjust the pH to 7.4. Then hearts were perfused with a solution supplemented with 0.896 mg/mL collagenase, 0.08 mg/mL protease type XIV, and 0.68 mg/mL bovine serum albumin for 15-20 min at 29°C. The left ventricles were dissected and gently triturated. Isolated cardiomyocytes were used within 4 h after isolation.
Patch-clamp experiments
The whole-cell configuration of the patch-clamp technique was used to record I Na in the voltage-clamp mode using a Multiclamp 700B amplifier (Molecular Devices) and pClamp 10.2 data acquisition software (Molecular Devices). The digital data were analyzed using pClampfit 10, Microcal Origin (OriginLab), and GraphPad Prism (Graph Pad Software) programs. Patch pipettes were pulled from a borosilicate glass (World Precision Instruments) using a DMZ Universal puller (Dagan). For the recording of I Na , cardiomyocytes were superfused with a bath solution containing (in mM): 135 NaCl, 4.6 CsCl, 1.8 CaCl 2 , 1.1 MgSO 4 , 10 HEPES, 10 glucose, and 0.01 nitrendipine (pH 7.4 adjusted with NaOH). Pipette resistance was 1.5-2 MΩ when filled with a pipette (internal) solution containing (in mM): 120 aspartic acid, 20 CsCl, 1 MgSO 4 , 4 ATPNa 2 , 0.1 GTPNa 3 , and 10 HEPES (pH 7.3 adjusted with CsOH). The recordings of I Na were performed at 22-24°C following a stabilization period (5-10 min) after establishing a patch with wholecell configuration. The myocytes were held at − 120 mV and depolarizing pulses (−20 mV, 220 ms) were applied at a rate of 1 Hz. The rate of decay (inactivation) of I Na was fitted using two exponential terms, and the slower component was used to describe I NaL .
Measurement of intracellular dye fluorescence
Experiments were performed using a LSM 5 PASCAL (Carl Zeiss) laser scanning confocal system equipped with a Zeiss PlanApochromat 40× 1. Fluo-3 K + salt (Life Technologies). The free Ca 2+ concentration in a solution was calculated using MAXChelator software (Stanford University). Fluo-3, Fluo-4, DCFDA, and MitoSOX Red were excited at 488 nm, and fluorescence signals were acquired at wavelengths N505 nm in the line scan mode or XY mode of the confocal system. Asante NaTRIUM Green and Asante NaTRIUM Green 2 were excited at 543 nm, and fluorescence was acquired at wavelengths N 560 nm in the XY scan mode. Fluorescent images were analyzed using ImageJ software (NIH) and Origin 8.1 (OriginLab).
We used exogenous CaMKII (New England Biolabs) to potentiate Ca 2+ signals in membrane-permeabilized cardiomyocytes [26] . CaMKII was pre-activated by incubation at 30°C in a CaMKII reaction buffer supplemented with 100 μmol/L ATP, 1.2 μmol/L calmodulin, and 2 mmol/L CaCl 2 for 10 min.
In the experiments on intact cells, myocytes were paced at 1 Hz. Fluorescent signals were recorded after 2 min of pacing before or after drug application. For experiments using membrane-permeabilized cells, fluorescence images were recorded within 5 min after membrane permeabilization. All measurements were done at a temperature of 22-24°C.
Western blot analysis
Western blot analyses were performed by a standard method. Antibodies for phospho-CaMKIIδ at threonine 286 and for GAPDH were purchased from Santa Cruz Biotechnology. Antibodies for PLN phosphorylated at threonine 17 and RyR2 phosphorylated at serine 2814 were purchased from Badrilla. To detect oxidized CaMKIIδ, an immune serum with antibodies directed against oxidized M281/M282 (ox-CaMKII) was used (polyclonal rabbit, 1:2500 dilution). Secondary antibody was horseradish peroxidase-linked goat anti-rabbit (1:1000) (PerkinElmer Life and Analytical Sciences). The relative intensity of individual bands from Western blots was quantitated using ImageJ software and normalized to GAPDH. The ratio for control was assigned a value of 1.
TAC mouse model of HF
Transverse aortic constriction (TAC) was performed on 3-month-old male CD-1 mice as previously described [27] . The presence of a TACinduced pressure gradient across the aortic constriction was verified using echocardiography. Serial echocardiography was done for data acquisition. Two-dimensional guided m-mode and 2D images were used to quantify and estimate LV luminal dimensions, systolic and diastolic functions, and fractional shortening. Only mice with an aortic pressure gradient N 30 mm Hg were used for experiments. Shamoperated animals were used as controls.
Statistics
All values were expressed as mean ± SEM. Statistical comparisons were made using unpaired Student's t-test or 2-way ANOVA for repeated measurements (p b 0.05).
Results
ATX-II increases I NaL in adult rabbit ventricular myocytes
To increase I NaL in rabbit ventricular myocytes, we superfused cells with 5 nM ATX-II for 30 min. Treatment with ATX-II caused a slowing of the rate of decay of Na + current induced by a depolarizing voltageclamp pulse, thereby increasing I NaL (Fig. 1A) . The time constants of I Na decay were 84.6 ± 9.5 ms in ATX-II treated cells and 47.8 ± 9.1 ms in control (vehicle-treated) cells. These results are consistent with previous findings that ATX-II causes slowing and incomplete inactivation of Na + channels, and increased I NaL [12, 19, 28] .
ATX-II increases Na
+ and ROS production, and causes Ca 2+ mishandling in rabbit ventricular myocytes
The I NaL enhancer ATX-II markedly increased the intracellular Na + concentration measured with the fluorescent dye Asante NaTRIUM Green in cardiomyocytes paced at a rate of 1 Hz. The value of F/F 0 , the intensity of dye fluorescence in the presence of ATX-II normalized to that before pacing and drug application, was 1.38 ± 0.04 ( Fig. 1Bi and Ci). Treatment with the late Na + current blockers ranolazine (10 μmol/L), tetrodotoxin (1 μmol/L), and GS-967 (1 μmol/L) in the presence of ATX-II reduced the values of F/F 0 to 1.16 ± 0.06, 1.18 ± 0.09, and 1.1 ± 0.04, respectively (Fig. 1Ci) . ATX-II also significantly increased the cytosolic ROS level (Fig. 1Bii and Cii). The F/F 0 value of DCFDA fluorescence was significantly increased from 1.02 ± 0.04 in control to 1.15 ± 0.02 in the presence of ATX-II (Fig. 1Cii) . Application of ranolazine, TTX or GS-967 significantly reduced cellular ROS production in the presence of ATX-II (F/F 0 values were 1.05 ± 0.03, 1.06 ± 0.06 and 1.05 ± 0.05, respectively).
Line-scan confocal images of cardiomyocytes loaded with Fluo-4 AM and paced at 1 Hz revealed an increase in the diastolic Ca 2+ level in the presence of ATX-II. The value of F/F 0 was increased from 1.0 ± 0.01 in control to 1.78 ± 0.09 in the presence of ATX-II ( Fig. 1Biii and Ciii Fig. 1Biii ).
Both ROS production and CaMKIIδ activation are essential for ATX-IIinduced abnormal intracellular Ca 2+ handling
To determine whether intracellular Ca 2+ mishandling depends on Na + -induced oxidative stress, we applied antioxidants to ATX-II-treated rabbit cardiomyocytes ( Fig. 2A, B) . ATX-II alone increased the number of Ca 2+ transients and the diastolic Ca 2+ level ( Fig. 2A, B) . ATX-II also increased the rate of leak of Ca 2+ from the SR (Supplemental Fig. 1 Fig. 2A, B) . CoQ10 also reduced cytosolic Na + levels in ATX-II-treated cardiomyocytes (Supplemental Fig. 2 ). Next we determined whether CaMKIIδ is involved in ATX-II-induced Ca 2+ mishandling. Application of a CaMKII inhibitor, either autocamtide inhibitory peptide (AIP, 1 μmol/L) or KN-93 (3 μmol/L), improved intracellular Ca 2+ handling in ATX-II-treated cells ( Fig. 2A, B) . By contrast, KN-92, a non-active analog of KN-93, had no effect. Western blot analysis revealed an increase in oxidation of CaMKIIδ at Met281/282 and autophosphorylation of CaMKIIδ at Thr287 (Fig. 2C, D) in the presence of 5 nmol/L ATX-II (Fig. 2C) . Antioxidants DTT and CoQ10 prevented the oxidation and phosphorylation of CaMKII in ATX-IItreated cells (Fig. 2C, D) . The effect of KN-93 (but not KN-92) was similar to that of the antioxidants. Furthermore, DTT, CoQ10 and KN-93 reduced phosphorylations of CaMKIIδ targets, RyR2 at serine 2814 and PLN at serine 17 ( Fig. 2C, D) , in the presence of ATX-II. These results suggest that ATX-II-induced ROS production may activate CaMKII. (Fig. 3A) . The presence of CoQ10 prevented such an acceleration (Fig. 3B) . The finding suggests that ROS plays a role in activation of Ca 2+ release from intracellular stores (e.g., sarcoplasmic reticulum) when the intracellular Na + concentration is raised. Activation of CaMKII by ROS is a potential mechanism of the effect. To verify the involvement of CaMKII in the response to 20 mmol/L Na (Fig. 3C) . As positive controls, permeabilized myocytes were incubated with exogenous pre-activated CaMKII (2 units activity/mL) or H 2 O 2 (100 μmol/L); these agents also induced an acceleration of the frequency of spontaneous Ca 2+ releases (Supplemental Figs. 3 and 4 ).
Elevated Na
An increase in intracellular Na + can cause Ca 2+ efflux from mitochondria, and has the potential to increase mitochondrial ROS production. Therefore, we used the mitochondria-specific ROS indicator MitoSOX Red to assess ROS production in mitochondria in membranepermeabilized cardiomyocytes exposed to 5 and 20 mmol/L Na (Fig. 3C ). These data are in accordance with previous observations [6, 10] .
3.5. Na + overload and oxidative stress in mouse TAC model of HF
To confirm whether Na + overload can cause ROS production and increase in diastolic Ca 2+ in the failing heart, we isolated cardiomyocytes from TAC mice with failing hearts. At 4 weeks after TAC, the mice developed cardiac hypertrophy (a 38% increase in the ratio of heart/body weight) and fractional shortening of LV myocardium was reduced (Fig. 4A) . It has been shown previously that the level of phosphorylation of CaMKII is increased in TAC hearts [29] . To determine whether TAC intervention changed oxidation of CaMKII we carried out Western blot analysis, which showed a significant increase in ox-CaMKII in TAC cardiac tissue when compared to sham tissue (Fig. 4B) . The level of intracellular Na + in paced myocytes isolated from TAC animals was significantly reduced by ranolazine (10 μmol/L) or TTX (1 μmol/L) (Fig. 4C) as indicated by decreases in fluorescence of the Na + -sensitive dye Asante NaTRIUM Green-2 to 74% and 78% of baseline, respectively. Neither ranolazine nor TTX reduced dye fluorescence in myocytes isolated from sham-operated animals (Supplemental Fig. 6 ). The antioxidant CoQ10 (10 μmol/L) and the CaMKII inhibitor KN-93 (3 μmol/L), but not KN-92, also significantly decreased Asante NaTRIUM Green-2 fluorescence relative to baseline in paced myocytes isolated from TAC mice (Fig. 4C) . Treatment of TAC myocytes with ranolazine (10 μmol/L) or TTX (1 μmol/L) also significantly decreased the fluorescence of DCFDA (a ROS-sensitive fluorescent indicator) by 72% and 80% relative to baseline, respectively (Fig. 4D) . The fluorescence of DCFDA was also decreased to 69% of baseline by CoQ10 (10 μmol/L) (Fig. 4D) . However, inhibition of CaMKII with KN-93 (3 μmol/L) did not significantly change the ROS level (Fig. 4D) . None of the studied drugs had an effect on basal Na + and ROS levels in myocytes isolated from sham-operated animals (Supplemental Fig. 6 ). Analysis of Ca 2+ transients in myocytes isolated from shamoperated and TAC animals indicated that the rise time of the transient was significantly longer in the TAC group (Supplemental Table 1 ). Spontaneous Ca 2+ releases following the termination of 1-Hz stimulations occurred more often in myocytes from TAC than in those isolated from sham animals (Fig. 4E) . Inhibition of I NaL by ranolazine (1 μmol/L) or CaMKII with KN-93 (3 μmol/L) normalized Ca 2+ transients and diminished spontaneous Ca 2+ waves in TAC myocytes (Fig. 4E , Supplemental Table I ) whereas KN-92 (3 μmol/L) had no effect.
Discussion
The goal of the present study was to elucidate potential pathways that connect the increases of I NaL and of the cytosolic Na + concentration (i.e., Na + overload) to disruption of intracellular Ca Fig. 1 ) and the frequency of SR Ca 2+ release events (Figs. 1, 2) , resulting in an increase of the cytosolic Ca 2+ concentration during diastole (Figs. 1, 2, 5) . This pathway appears to be operative in myocytes of failing hearts. Our findings are consistent with and expand on the previously reported links between cytosolic Na + overload and mitochondrial ROS generation [6, 7] and between oxidized CaMKII and Ca 2+ overload [2, 11, 12, 18, 30, 31] .
Contribution of I NaL to Na + influx
In the present research we used I NaL enhancement (Fig. 1) as a tool to increase cytosolic Na + load. I NaL that occurs during the plateau of the action potential has been shown by many investigators to cause AP prolongation. I NaL can account for 30% or more of Na + influx through myocyte Na + channels [32] . Other potential sources of Na + entry via Na + channels are "window current" [33] , and "background current"
near the threshold of Na + channel activation [34] . They are not usually called I NaL , which typically refers to current at plateau potentials due to failure of open state inactivation of Na + channels, but they can be blocked by ranolazine and TTX and may have contributed to Na + entry in this study. The effects of CaMKII, oxidation, and diseases on window and background Na + currents are poorly understood.
Our results indicate that the decay time constant of I NaL in ATX-II (5 nM)-treated rabbit cardiomyocytes was prolonged 1.5-2-fold. This prolongation is similar in magnitude to that found in myocytes from failing hearts in TAC mice [29] . This suggests that the increase of I NaL is comparable in both models. Therefore, we believe that the effect of ATX-II on rabbit myocytes in this study is not so large as to be irrelevant to an understanding of its potential pathological effects in failing hearts, and to the mechanisms by which the effect of Na + overload (regardless of its cause) is mediated.
Na + overload induced mitochondrial ROS generation
The detrimental influence of intracellular Na + overload on cardiac cell function is well recognized [3] [4] [5] 8, 12, [19] [20] [21] . The prevailing view of the pathway that connects cytosolic Na + accumulation to altered Ca 2+ homeostasis has focused on the role of the sarcolemmal Na + - (Fig. 3) .
Our observations that ATX-II promotes elevated ROS production ( Fig. 1) and that deleterious consequences of Na + overload are attenuated by antioxidants such as CoQ10 and DTT (Figs. 2, 3 ) are in agreement with a growing body of evidence demonstrating that Na + overload promotes cellular oxidative stress. Kohlhaas et al. [7] recently described a series of experiments demonstrating that elevation of cytosolic Na + is sufficient to induce mitochondrial ROS generation. In patch clamped guinea-pig cardiomyocytes, elevation of cytosolic Na + from 5 to 15 mmol/L resulted in mitochondrial Ca 2+ extrusion with a concurrent increase in H 2 O 2 generation, effects which were blocked by the mitochondrial Na + -Ca 2+ exchange inhibitor CGP-37157 [7] . These authors [7] suggest that Na + overload promotes mitochondrial Ca 2+ efflux, resulting in H 2 O 2 accumulation as a consequence of impaired NADPH-dependent mitochondrial antioxidant capacity. In our study, using permeabilized myocytes, we confirmed that Na + overload can increase mitochondrial ROS production (Supplemental Fig. 5 ) and that Na + -induced Ca 2 + mishandling is attenuated by CGP-37157 (Fig. 3C ), in agreement with Kohlhaas et al. [7] . Involvement of the mitochondrial Na + -Ca 2+ exchanger in this mechanism assumes that mitochondrial Na + and Ca 2 + concentrations should be altered by cytosolic Na + overload. Changes in either Na + or Ca 2 + concentration can induce mitochondrial dysfunction. Reduction of mitochondrial Ca 2 + efflux in Na + -overloaded myocytes may explain effect of ranolazine (which can reduce I NaL and the cytosolic Na + concentration [19, 20] and can indirectly increase the activity of mitochondrial dehydrogenases such as pyruvate dehydrogenase that rely on mitochondrial Ca 2 + for their activity [35, 36] ).
However, it should be noted that the mechanisms of increased mitochondrial ROS generation are only partially understood. A novel observation in this study was that CaMKII oxidation was increased subsequent to an elevation by ATX-II of the intracellular Na + concentration in intact cardiomyocytes (Fig. 2C, D) and TAC cardiac tissue (Fig. 4B) . ATX-II-induced CaMKII oxidation was detected using an antibody that specifically recognizes the oxidized methionine 281/282 site on CaMKII [30] . In parallel to the increase in oxidized-CaMKII, we observed an ATX-II-induced increase in CaMKII phosphorylation at Thr287, demonstrating increased autophosphorylation (Fig. 2C, D) . These results are in agreement with previous studies demonstrating that CaMKII oxidation is accompanied by an increase in CaMKII autophosphorylation [11, 30, 31] . Importantly, the increases in CaMKII oxidation and phosphorylation were accompanied by an elevation in the phosphorylation of CaMKII substrates involved in Ca 2+ handling, including PLN and RyR2 (Fig. 2C, D arrhythmic activity in the presence of ATX-II (Fig. 2B) . Similarly, KN-93 and CoQ10 also prevented aberrant Ca 2+ handling induced by elevated cytosolic Na + in permeabilized cardiomyocytes (Fig. 3) .
Furthermore, treatment of permeabilized cells with exogenous, preactivated phosphorylated CaMKII accelerated the frequency of spontaneous Ca 2+ waves and increased diastolic Ca 2+ (Supplemental Fig. 3 ).
The effects of pre-activated CaMKII were strikingly similar to those observed after elevation of the intracellular Na + concentration in permeabilized myocytes (Fig. 3) . Taken together, our data provide evidence that CaMKII activity is both necessary and sufficient to induce maladaptive Ca 2+ handling in cardiomyocytes, and it acts as both a sensor for, and an effector of responses to, an increase in ROS production [11, 30, 31] . of, the sarcoplasmic reticulum [41] . The finding that oxidation and phosphorylation of CaMKII were increased in myocytes exposed to the I NaL enhancer ATX-II is in accord with previous reports [12] . Thus, CaMKII activation, including activation through an oxidation-dependent pathway, is a key element in a complex interplay between Na + load and Ca 2+ handling under pathological conditions [12, 17, 18, 31, 38, 39] .
TAC data and relevance to heart failure
Increases of I NaL and CaMKII activity are well documented in cardiomyocytes isolated from failing hearts of experimental animals [5, 17, 20, 42] and human patients [20, 42] . Toischer et al. recently reported roles for I NaL and CaMKII in the progression of pressure-overload induced heart disease after TAC in mice [29] . In their study, I NaL was not enhanced during the compensatory hypertrophy stage (1 week post-TAC) but was significantly enhanced in hearts that had developed heart failure (5 weeks post-TAC) characterized by a reduced ejection fraction. In parallel to the increase in I NaL observed in failing myocytes, there was a significant increase in both CaMKII autophosphorylation and phosphorylation of Na V 1.5 at the CaMKII site ser-571, when compared to myocytes isolated from non-failing hearts or from hearts in the compensatory hypertrophy stage [29] . In the present study, we utilized a similar model of pressure overload-induced heart failure in mice to examine the contributions of I NaL , CaMKII and ROS to maladaptive Ca 2+ handling in the failing heart. Heart failure was induced by 4 weeks TAC, as evidenced by a significant reduction in fractional shortening of left ventricular myocardium, relative to sham-operated mice (Fig. 4A) . Importantly, the level of ox-CaMKII was increased in cardiac tissue of TAC animals relative to sham animals (Fig. 4B) . Cardiomyocytes isolated from failing hearts had evidence of maladaptive Ca 2+ handling, manifested as an increase in spontaneous Ca 2+ release events (Fig. 4D) . The frequency of Ca 2+ release events was normalized after treatment of myocytes with I NaL inhibitor ranolazine or CaMKII inhibitor KN-93. Treatment with ranolazine, KN-93 or CoQ10 all reduced cellular Na + , whereas ROS was reduced by either CoQ10 or ranolazine, but not by KN-93, because elevation of ROS production can occur in the absence of CaMKII activation (Fig. 5) . None of these agents had an effect on the cytosolic Na + concentration or on ROS production in myocytes isolated from non-failing hearts (Supplemental Fig. 6 ). Taken together with the work of Toischer et al. [29] our findings suggest that I NaL -induced Na + overload, oxidative stress, and CaMKII activity likely contribute to pro-arrhythmic Ca 2+ mishandling in the failing heart.
Conclusions
Our results provide experimental evidence that CaMKIIδ oxidation subsequent to mitochondrial ROS generations induced by cytosolic Na + overload is an important component of an intracellular signaling pathway ( Fig. 5) 
